fenofibrate has been researched along with Bile Duct Obstruction, Intrahepatic in 7 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Grady, J | 1 |
| Clifford, C | 1 |
| Treadwell, MC | 1 |
| Parikh, ND | 1 |
| Satishchandran, A | 1 |
| Dai, M | 1 |
| Yang, J | 1 |
| Xie, M | 1 |
| Lin, J | 1 |
| Luo, M | 1 |
| Hua, H | 1 |
| Xu, G | 1 |
| Lin, H | 1 |
| Song, D | 1 |
| Cheng, Y | 1 |
| Guo, B | 1 |
| Zhao, J | 1 |
| Gonzalez, FJ | 1 |
| Liu, A | 1 |
| Zhao, Q | 1 |
| Yang, R | 1 |
| Wang, J | 1 |
| Hu, DD | 1 |
| Li, F | 1 |
| Hajdu, D | 1 |
| Aiglová, K | 1 |
| Vinklerová, I | 1 |
| Urbánek, K | 1 |
| Moustafa, T | 1 |
| Fickert, P | 1 |
| Magnes, C | 1 |
| Guelly, C | 1 |
| Thueringer, A | 1 |
| Frank, S | 1 |
| Kratky, D | 1 |
| Sattler, W | 1 |
| Reicher, H | 1 |
| Sinner, F | 1 |
| Gumhold, J | 1 |
| Silbert, D | 1 |
| Fauler, G | 1 |
| Höfler, G | 1 |
| Lass, A | 1 |
| Zechner, R | 1 |
| Trauner, M | 1 |
| Pichon, N | 1 |
| Vincensini, JF | 1 |
| Rozière, A | 1 |
| Labrousse, F | 1 |
| Sautereau, D | 1 |
| Pillegand, B | 1 |
| Lepicard, A | 1 |
| Mallat, A | 1 |
| Zafrani, ES | 1 |
| Dhumeaux, D | 1 |
7 other studies available for fenofibrate and Bile Duct Obstruction, Intrahepatic
| Article | Year |
|---|---|
Use of fenofibrate for intrahepatic cholestasis of pregnancy.
Topics: Cholestasis, Intrahepatic; Female; Fenofibrate; Humans; Pregnancy; Pregnancy Complications | 2023 |
Inhibition of JNK signalling mediates PPARα-dependent protection against intrahepatic cholestasis by fenofibrate.
Topics: 1-Naphthylisothiocyanate; Animals; Anthracenes; Cholestasis, Intrahepatic; Dose-Response Relationshi | 2017 |
PPARα activation protects against cholestatic liver injury.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Disease Models, Animal; | 2017 |
Acute cholestatic hepatitis induced by fenofibrate.
Topics: Acute Disease; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Female; Fenofibrat | 2009 |
Alterations in lipid metabolism mediate inflammation, fibrosis, and proliferation in a mouse model of chronic cholestatic liver injury.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP-Binding Cassette Sub-Family B Member 4; | 2012 |
[Acute cytolytic and cholestatic hepatitis induced by fenofibrate].
Topics: Acute Disease; Chemical and Drug Induced Liver Injury; Cholestasis, Intrahepatic; Fenofibrate; Human | 2003 |
[Chronic lesion of the interlobular bile ducts induced by fenofibrate].
Topics: Cholestasis, Intrahepatic; Chronic Disease; Female; Fenofibrate; Humans; Hypercholesterolemia; Liver | 1994 |